Chelsea Therapeutics, Inc.
3530 Toringdon Way
Suite 200
Charlotte
North Carolina
28277
United States
Tel: 704-341-1516
Fax: 704-752-1479
Website: http://www.chelseatherapeutics.com/
225 articles about Chelsea Therapeutics, Inc.
-
Galleon Taps Ex-Chelsea Therapeutics Chief as New CEO
8/4/2015
-
H. Lundbeck A/S Completes Acquisition Of Chelsea Therapeutics, Inc.
6/24/2014
-
Lundbeck Inc. Successfully Completes Tender Offer For Chelsea Therapeutics, Inc.
6/23/2014
-
Chelsea Therapeutics, Inc. Release: NORTHERA™ Clinical Trial Data Published in Neurology
6/20/2014
-
Chelsea Therapeutics, Inc. Presents Efficacy And Safety Data For NORTHERA At International Congress Of Parkinson's Disease And Movement Disorders
6/12/2014
-
Chelsea Therapeutics, Inc. Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S
6/6/2014
-
H. Lundbeck A/S Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc.
5/23/2014
-
Lundbeck Inc. Swallows Up Chelsea Therapeutics, Inc. In Deal Worth $658 Million
5/9/2014
-
Chelsea Therapeutics, Inc. Reports Fourth Quarter And Full-Year 2013 Results
3/12/2014
-
Chelsea Therapeutics, Inc. Joins National Organization for Rare Disorders In Promoting Awareness For Rare Disease Day
2/28/2014
-
Chelsea Therapeutics, Inc. Pops As FDA Finally Approves NORTHERA
2/19/2014
-
Nervous Chelsea Therapeutics, Inc. Still Awaiting News From The FDA On NORTHERA
2/18/2014
-
Chelsea Therapeutics, Inc. Names Keith W. Schmidt Chief Commercial Officer
1/30/2014
-
Chelsea Therapeutics, Inc. Announces Joseph G. Oliveto Named President And Chief Executive Officer, Director
1/27/2014
-
Chelsea Therapeutics, Inc. Rockets Before Market Opens After Northera Finally Wins FDA Panel Backing
1/15/2014
-
Chelsea Therapeutics, Inc. Blues: FDA Reviewer Still Finds Problems With Fainting Drug Northera
1/13/2014
-
Chelsea Therapeutics, Inc. Announces First Patient Dosed In NORTHERA™ (Droxidopa) Study 401 For The Treatment Of Symptomatic NOH
12/9/2013
-
Chelsea Therapeutics, Inc. Completes Public Offering Of Common Stock
11/18/2013
-
Chelsea Therapeutics, Inc. Announces Public Offering of Common Stock
11/13/2013
-
Chelsea Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
11/13/2013